{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:09:17Z","timestamp":1793398157793,"version":"4.5.0"},"publisher-location":"Cham","reference-count":115,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030216368","type":"print"},{"value":"9783030217358","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-21735-8_10","type":"book-chapter","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T13:03:27Z","timestamp":1569589407000},"page":"101-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Metabolomics Biomarkers for Precision Psychiatry"],"prefix":"10.1007","author":[{"given":"Pei-an (Betty)","family":"Shih","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,28]]},"reference":[{"issue":"3","key":"10_CR1","first-page":"149","volume":"6","author":"JC Wakefield","year":"2007","unstructured":"Wakefield JC (2007) The concept of mental disorder: diagnostic implications of the harmful dysfunction analysis. World Psychiat 6(3):149\u2013156","journal-title":"World Psychiat"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev.publhealth.29.020907.090847","volume":"29","author":"RC Kessler","year":"2008","unstructured":"Kessler RC, Wang PS (2008) The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health 29:115\u2013129","journal-title":"Annu Rev Public Health"},{"issue":"6","key":"10_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1192\/bjp.bp.111.097519","volume":"200","author":"R Bruffaerts","year":"2012","unstructured":"Bruffaerts R, Vilagut G, Demyttenaere K, Alonso J, Alhamzawi A, Andrade LH et al (2012) Role of common mental and physical disorders in partial disability around the world. Br J Psychiat 200(6):454\u2013461","journal-title":"Br J Psychiat"},{"issue":"4","key":"10_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jamapsychiatry.2014.2502","volume":"72","author":"ER Walker","year":"2015","unstructured":"Walker ER, McGee RE, Druss BG (2015) Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiat 72(4):334\u2013341","journal-title":"JAMA Psychiat"},{"issue":"2","key":"10_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2215-0366(15)00505-2","volume":"3","author":"D Vigo","year":"2016","unstructured":"Vigo D, Thornicroft G, Atun R (2016) Estimating the true global burden of mental illness. Lancet Psychiatry 3(2):171\u2013178","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.genhosppsych.2007.03.009","volume":"29","author":"J Ormel","year":"2007","unstructured":"Ormel J, Von Korff M, Burger H, Scott K, Demyttenaere K, Huang YQ et al (2007) Mental disorders among persons with heart disease\u00a0\u2013 results from World Mental Health surveys. Gen Hosp Psychiatry 29(4):325\u2013334","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"10_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.genhosppsych.2012.06.006","volume":"34","author":"DP Goldberg","year":"2012","unstructured":"Goldberg DP, Prisciandaro JJ, Williams P (2012) The primary health care version of ICD-11: the detection of common mental disorders in general medical settings. Gen Hosp Psychiatry 34(6):665\u2013670","journal-title":"Gen Hosp Psychiatry"},{"key":"10_CR8","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (ed) (2013) American psychiatric association, diagnostic and statistical manual of mental disorders, 5th edn. Washington, DC","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"5","key":"10_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/09540260701564914","volume":"19","author":"RC Kessler","year":"2007","unstructured":"Kessler RC (2007) Psychiatric epidemiology: challenges and opportunities. Int Rev Psychiatry 19(5):509\u2013521","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"10_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1529100617727266","volume":"18","author":"LA Clark","year":"2017","unstructured":"Clark LA, Cuthbert B, Lewis-Fernandez R, Narrow WE, Reed GM (2017) Three approaches to understanding and classifying mental disorder: ICD-11, DSM-5, and the National Institute of Mental Health\u2019s Research Domain Criteria (RDoC). Psychol Sci Public Interest 18(2):72\u2013145","journal-title":"Psychol Sci Public Interest"},{"issue":"10","key":"10_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3928\/02793695-20081001-05","volume":"46","author":"RH Howland","year":"2008","unstructured":"Howland RH (2008) Sequenced treatment alternatives to relieve depression (STAR\u2217D). Part 2: study outcomes. J Psychosoc Nurs Ment Health Serv 46(10):21\u201324","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10_CR12","unstructured":"National research council committee on a framework for developing a new taxonomy of disease (2011) National Academies Press, Washington, DC"},{"issue":"9","key":"10_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372(9):793\u2013795","journal-title":"N Engl J Med"},{"issue":"1","key":"10_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin Y, Seldin M, Lusis A (2017) Multi-omics approaches to disease. Genome Biol 18(1):83","journal-title":"Genome Biol"},{"issue":"5","key":"10_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41588-018-0090-3","volume":"50","author":"NR Wray","year":"2018","unstructured":"Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A et al (2018) Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 50(5):668\u2013681","journal-title":"Nat Genet"},{"issue":"7510","key":"10_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511(7510):421\u2013427","journal-title":"Nature"},{"issue":"9","key":"10_CR17","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/ng.2711","volume":"45","author":"SH Lee","year":"2013","unstructured":"Cross-Disorder Group of the Psychiatric Genomics C, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM et al (2013) Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45(9):984\u2013994","journal-title":"Nat Genet"},{"issue":"1","key":"10_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/HRP.0000000000000203","volume":"27","author":"ET Ward","year":"2019","unstructured":"Ward ET, Kostick KM, Lazaro-Munoz G (2019) Integrating genomics into psychiatric practice: ethical and legal challenges for clinicians. Harv Rev Psychiatry 27(1):53\u201364","journal-title":"Harv Rev Psychiatry"},{"issue":"1","key":"10_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","volume":"101","author":"PM Visscher","year":"2017","unstructured":"Visscher PM, Wray NR, Zhang Q, Sklar P, McCarthy MI, Brown MA et al (2017) 10 years of GWAS discovery: biology, function, and translation. Am J Hum Genet 101(1):5\u201322","journal-title":"Am J Hum Genet"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/bs.adgen.2015.11.004","volume":"93","author":"YV Sun","year":"2016","unstructured":"Sun YV, Hu YJ (2016) Integrative analysis of multi-omics data for discovery and functional studies of complex human diseases. Adv Genet 93:147\u2013190","journal-title":"Adv Genet"},{"key":"10_CR21","unstructured":"Brainstorm C, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J et\u00a0al (2018) Analysis of shared heritability in common disorders of the brain. Science 360(6395)"},{"issue":"5","key":"10_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/mp.2011.42","volume":"17","author":"E Schwarz","year":"2012","unstructured":"Schwarz E, Guest PC, Rahmoune H, Harris LW, Wang L, Leweke FM et al (2012) Identification of a biological signature for schizophrenia in serum. Mol Psychiatry 17(5):494\u2013502","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"G Biomarkers Definitions Working","year":"2001","unstructured":"Biomarkers Definitions Working G (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89\u201395","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/omi.2016.0110","volume":"20","author":"S Dalvie","year":"2016","unstructured":"Dalvie S, Koen N, McGregor N, O\u2019Connell K, Warnich L, Ramesar R et al (2016) Toward a global roadmap for precision medicine in psychiatry: challenges and opportunities. OMICS 20(10):557\u2013564","journal-title":"OMICS"},{"issue":"10","key":"10_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11306-016-1094-6","volume":"12","author":"RD Beger","year":"2016","unstructured":"Beger RD, Dunn W, Schmidt MA, Gross SS, Kirwan JA, Cascante M et al (2016) Metabolomics enables precision medicine: \u201ca white paper, community perspective\u201d. Metabolomics 12(10):149","journal-title":"Metabolomics"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.prostaglandins.2017.02.002","volume":"132","author":"PB Shih","year":"2017","unstructured":"Shih PB (2017) Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa. Prostaglandins Other Lipid Mediat 132:69\u201376","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-1258-2_1","volume":"1198","author":"GA Gowda","year":"2014","unstructured":"Gowda GA, Djukovic D (2014) Overview of mass spectrometry-based metabolomics: opportunities and challenges. Methods Mol Biol 1198:3\u201312","journal-title":"Methods Mol Biol"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.copbio.2016.08.001","volume":"43","author":"JL Markley","year":"2017","unstructured":"Markley JL, Bruschweiler R, Edison AS, Eghbalnia HR, Powers R, Raftery D et al (2017) The future of NMR-based metabolomics. Curr Opin Biotechnol 43:34\u201340","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"10_CR29","first-page":"5","volume":"32","author":"SK Grebe","year":"2011","unstructured":"Grebe SK, Singh RJ (2011) LC-MS\/MS in the clinical laboratory\u00a0\u2013 where to from here? Clinical Biochem Rev 32(1):5\u201331","journal-title":"Clinical Biochem Rev"},{"issue":"7","key":"10_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol 17(7):451\u2013459","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.psychres.2017.02.056","volume":"252","author":"M Hennebelle","year":"2017","unstructured":"Hennebelle M, Otoki Y, Yang J, Hammock BD, Levitt AJ, Taha AY et al (2017) Altered soluble epoxide hydrolase-derived oxylipins in patients with seasonal major depression: an exploratory study. Psychiatry Res 252:94\u2013101","journal-title":"Psychiatry Res"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.schres.2016.12.024","volume":"185","author":"L Tasic","year":"2017","unstructured":"Tasic L, Pontes JGM, Carvalho MS, Cruz G, Dal Mas C, Sethi S et al (2017) Metabolomics and lipidomics analyses by (1)H nuclear magnetic resonance of schizophrenia patient serum reveal potential peripheral biomarkers for diagnosis. Schizophr Res 185:182\u2013189","journal-title":"Schizophr Res"},{"issue":"10","key":"10_CR33","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1017\/S1461145713000928","volume":"16","author":"HY Meltzer","year":"2013","unstructured":"Meltzer HY, Rajagopal L, Huang M, Oyamada Y, Kwon S, Horiguchi M (2013) Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia. Int J Neuropsychopharmacol 16(10):2181\u20132194","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/mp.2011.131","volume":"18","author":"J Yang","year":"2013","unstructured":"Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K et al (2013) Potential metabolite markers of schizophrenia. Mol Psychiatry 18(1):67\u201378","journal-title":"Mol Psychiatry"},{"issue":"8","key":"10_CR35","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1371\/journal.pmed.0030327","volume":"3","author":"E Holmes","year":"2006","unstructured":"Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW et al (2006) Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 3(8):e327","journal-title":"PLoS Med"},{"issue":"1","key":"10_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4088\/JCP.12m08001","volume":"74","author":"H Jin","year":"2013","unstructured":"Jin H, Shih P-aB, Golshan S, Mudaliar S, Henry R, Glorioso DK et al (2013) Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. J Clin Psychiatry 74(1):11\u201319","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068717","volume":"8","author":"J McEvoy","year":"2013","unstructured":"McEvoy J, Baillie RA, Zhu H, Buckley P, Keshavan MS, Nasrallah HA et al (2013) Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. PLoS One 8(7):e68717","journal-title":"PLoS One"},{"issue":"11","key":"10_CR38","doi-asserted-by":"publisher","first-page":"e951","DOI":"10.1038\/tp.2016.222","volume":"6","author":"T Suvitaival","year":"2016","unstructured":"Suvitaival T, Mantere O, Kieseppa T, Mattila I, Poho P, Hyotylainen T et al (2016) Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis. Transl Psychiatry 6(11):e951","journal-title":"Transl Psychiatry"},{"issue":"12","key":"10_CR39","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1021\/pr2006796","volume":"10","author":"J Xuan","year":"2011","unstructured":"Xuan J, Pan G, Qiu Y, Yang L, Su M, Liu Y et al (2011) Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action. J Proteome Res 10(12):5433\u20135443","journal-title":"J Proteome Res"},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jad.2016.02.008","volume":"195","author":"P Zheng","year":"2016","unstructured":"Zheng P, Fang Z, Xu XJ, Liu ML, Du X, Zhang X et al (2016) Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells. J Affect Disord 195:75\u201381","journal-title":"J Affect Disord"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbr.2017.06.012","volume":"332","author":"JJ Chen","year":"2017","unstructured":"Chen JJ, Zhou CJ, Zheng P, Cheng K, Wang HY, Li J et\u00a0al (2017) Differential urinary metabolites related with the severity of major depressive disorder. Behav Brain Res 332:280\u2013287","journal-title":"Behav Brain Res"},{"issue":"5","key":"10_CR42","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/gps.1690","volume":"22","author":"LA Paige","year":"2007","unstructured":"Paige LA, Mitchell MW, Krishnan KR, Kaddurah-Daouk R, Steffens DC (2007) A preliminary metabolomic analysis of older adults with and without depression. Int J Geriatr Psychiatry 22(5):418\u2013423","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"10_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/0891988709358592","volume":"23","author":"DC Steffens","year":"2010","unstructured":"Steffens DC, Wei J, Krishnan KR, Karoly ED, Mitchell MW, O\u2019Connor CM et al (2010) Metabolomic differences in heart failure patients with and without major depression. J Geriatr Psychiatry Neurol 23(2):138\u2013146","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"7","key":"10_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068283","volume":"8","author":"H Zhu","year":"2013","unstructured":"Zhu H, Bogdanov MB, Boyle SH, Matson W, Sharma S, Matson S et al (2013) Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder\u00a0\u2013 possible role for methoxyindole pathway. PLoS One 8(7):e68283","journal-title":"PLoS One"},{"issue":"12","key":"10_CR45","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1038\/mp.2016.6","volume":"21","author":"M Gupta","year":"2016","unstructured":"Gupta M, Neavin D, Liu D, Biernacka J, Hall-Flavin D, Bobo WV et al (2016) TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics. Mol Psychiatry 21(12):1717\u20131725","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41398-018-0349-6","volume":"9","author":"AH Czysz","year":"2019","unstructured":"Czysz AH, South C, Gadad BS, Arning E, Soyombo A, Bottiglieri T et al (2019) Can targeted metabolomics predict depression recovery? Results from the CO-MED trial. Transl Psychiatry 9(1):11","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40345-017-0088-2","volume":"5","author":"S Sethi","year":"2017","unstructured":"Sethi S, Pedrini M, Rizzo LB, Zeni-Graiff M, Mas CD, Cassinelli AC et al (2017) (1)H-NMR, (1)H-NMR T2-edited, and 2D-NMR in bipolar disorder metabolic profiling. Int J Bipolar Disord 5(1):23","journal-title":"Int J Bipolar Disord"},{"key":"10_CR48","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.1038\/srep05855","volume":"4","author":"JJ Chen","year":"2014","unstructured":"Chen JJ, Liu Z, Fan SH, Yang DY, Zheng P, Shao WH et al (2014) Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. Sci Rep 4:5855","journal-title":"Sci Rep"},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.psychres.2017.08.039","volume":"258","author":"HC Ribeiro","year":"2017","unstructured":"Ribeiro HC, Klassen A, Pedrini M, Carvalho MS, Rizzo LB, Noto MN et al (2017) A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics. Psychiatry Res 258:268\u2013273","journal-title":"Psychiatry Res"},{"issue":"7","key":"10_CR50","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1139\/y91-136","volume":"69","author":"SN Young","year":"1991","unstructured":"Young SN (1991) The 1989 Borden Award Lecture. Some effects of dietary components (amino acids, carbohydrate, folic acid) on brain serotonin synthesis, mood, and behavior. Can J Physiol Pharmacol 69(7):893\u2013903","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"10_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neulet.2007.04.086","volume":"421","author":"SM Conklin","year":"2007","unstructured":"Conklin SM, Gianaros PJ, Brown SM, Yao JK, Hariri AR, Manuck SB et al (2007) Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett 421(3):209\u2013212","journal-title":"Neurosci Lett"},{"issue":"5","key":"10_CR52","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/WNL.0000000000000080","volume":"82","author":"JV Pottala","year":"2014","unstructured":"Pottala JV, Yaffe K, Robinson JG, Espeland MA, Wallace R, Harris WS (2014) Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology 82(5):435\u2013442","journal-title":"Neurology"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2017.01.001","volume":"66","author":"E Messamore","year":"2017","unstructured":"Messamore E, Almeida DM, Jandacek RJ, McNamara RK (2017) Polyunsaturated fatty acids and recurrent mood disorders: phenomenology, mechanisms, and clinical application. Prog Lipid Res 66:1\u201313","journal-title":"Prog Lipid Res"},{"issue":"5","key":"10_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096905","volume":"9","author":"G Grosso","year":"2014","unstructured":"Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C et al (2014) Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 9(5):e96905","journal-title":"PLoS One"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jad.2014.07.032","volume":"169","author":"JJ Young","year":"2014","unstructured":"Young JJ, Bruno D, Pomara N (2014) A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord 169:15\u201320","journal-title":"J Affect Disord"},{"key":"10_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neures.2016.11.002","volume":"115","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Matsuda T, Hayes LN, Yang S, Rodriguez K, Severance EG et al (2017) Infection and inflammation in schizophrenia and bipolar disorder. Neurosci Res 115:59\u201363","journal-title":"Neurosci Res"},{"issue":"9","key":"10_CR57","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1194\/jlr.P085118","volume":"59","author":"AM Valdes","year":"2018","unstructured":"Valdes AM, Ravipati S, Pousinis P, Menni C, Mangino M, Abhishek A et al (2018) Omega-6 oxylipins generated by soluble epoxide hydrolase are associated with knee osteoarthritis. J Lipid Res 59(9):1763\u20131770","journal-title":"J Lipid Res"},{"issue":"5","key":"10_CR58","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8(5):349\u2013361","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10_CR59","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbalip.2014.07.020","volume":"1851","author":"AA Spector","year":"2015","unstructured":"Spector AA, Kim HY (2015) Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochim Biophys Acta 1851(4):356\u2013365","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10_CR60","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/HYPERTENSIONAHA.114.03585","volume":"65","author":"JD Imig","year":"2015","unstructured":"Imig JD (2015) Epoxyeicosatrienoic acids, hypertension, and kidney injury. Hypertension 65(3):476\u2013482","journal-title":"Hypertension"},{"issue":"6","key":"10_CR61","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.yjmcc.2009.08.017","volume":"47","author":"N Li","year":"2009","unstructured":"Li N, Liu JY, Timofeyev V, Qiu H, Hwang SH, Tuteja D et al (2009) Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches. J Mol Cell Cardiol 47(6):835\u2013845","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"10_CR62","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10555-010-9264-x","volume":"29","author":"D Panigrahy","year":"2010","unstructured":"Panigrahy D, Kaipainen A, Greene ER, Huang S (2010) Cytochrome P450-derived eicosanoids: the neglected pathway in cancer. Cancer Metastasis Rev 29(4):723\u2013735","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"10_CR63","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/mp.2015.26","volume":"21","author":"PB Shih","year":"2016","unstructured":"Shih PB, Yang J, Morisseau C, German JB, Zeeland AA, Armando AM et al (2016) Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa. Mol Psychiatry 21(4):537\u2013546","journal-title":"Mol Psychiatry"},{"key":"10_CR64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jpsychires.2018.04.002","volume":"102","author":"D Wang","year":"2018","unstructured":"Wang D, Sun X, Yan J, Ren B, Cao B, Lu Q et al (2018) Alterations of eicosanoids and related mediators in patients with schizophrenia. J Psychiatr Res 102:168\u2013178","journal-title":"J Psychiatr Res"},{"issue":"8","key":"10_CR65","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.metabol.2013.02.004","volume":"62","author":"MA Zulyniak","year":"2013","unstructured":"Zulyniak MA, Perreault M, Gerling C, Spriet LL, Mutch DM (2013) Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men. Metabolism 62(8):1107\u20131113","journal-title":"Metabolism"},{"issue":"3","key":"10_CR66","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3733\/ca.v065n03p106","volume":"65","author":"AM Zivkovic","year":"2011","unstructured":"Zivkovic AM, Telis N, German JB, Hammock BD (2011) Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health. Calif Agric (Berkeley) 65(3):106\u2013111","journal-title":"Calif Agric (Berkeley)"},{"key":"10_CR67","volume":"2015","author":"J Thomas","year":"2015","unstructured":"Thomas J, Thomas CJ, Radcliffe J, Itsiopoulos C (2015) Omega-3 fatty acids in early prevention of inflammatory neurodegenerative disease: a focus on Alzheimer\u2019s disease. Biomed Res Int 2015:172801","journal-title":"Biomed Res Int"},{"issue":"9","key":"10_CR68","first-page":"1137","volume":"16","author":"B Sears","year":"2012","unstructured":"Sears B, Ricordi C (2012) Role of fatty acids and polyphenols in inflammatory gene transcription and their impact on obesity, metabolic syndrome and diabetes. Eur Rev Med Pharmacol Sci 16(9):1137\u20131154","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10_CR69","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.bbrc.2018.03.081","volume":"504","author":"HC Lee","year":"2018","unstructured":"Lee HC, Yokomizo T (2018) Applications of mass spectrometry-based targeted and non-targeted lipidomics. Biochem Biophys Res Commun 504(3):576\u2013581","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10_CR70","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1194\/jlr.M009449","volume":"51","author":"O Quehenberger","year":"2010","unstructured":"Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH et al (2010) Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res 51(11):3299\u20133305","journal-title":"J Lipid Res"},{"issue":"4","key":"10_CR71","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/nu9040325","volume":"9","author":"Mirjana Veselinovic","year":"2017","unstructured":"Veselinovic M, Vasiljevic D, Vucic V, Arsic A, Petrovic S, Tomic-Lucic A et al (2017) Clinical benefits of n-3 PUFA and -linolenic acid in patients with rheumatoid arthritis. Nutrients 9(4)","journal-title":"Nutrients"},{"key":"10_CR72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-511X-7-24","volume":"7","author":"P Magee","year":"2008","unstructured":"Magee P, Pearson S, Allen J (2008) The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumour necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiation. Lipids Health Dis 7:24","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10_CR73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.plefa.2012.05.008","volume":"88","author":"SK Orr","year":"2013","unstructured":"Orr SK, Trepanier MO, Bazinet RP (2013) n-3 Polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot Essent Fatty Acids 88(1):97\u2013103","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"10_CR74","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/ajmg.b.32567","volume":"174","author":"R Alam","year":"2017","unstructured":"Alam R, Abdolmaleky HM, Zhou JR (2017) Microbiome, inflammation, epigenetic alterations, and mental diseases. Am J Med Genet B Neuropsychiatr Genet 174(6):651\u2013660","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"10","key":"10_CR75","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.nut.2013.01.012","volume":"29","author":"UN Das","year":"2013","unstructured":"Das UN (2013) Autism as a disorder of deficiency of brain-derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids. Nutrition 29(10):1175\u20131185","journal-title":"Nutrition"},{"key":"10_CR76","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pnpbp.2012.06.010","volume":"42","author":"UN Das","year":"2013","unstructured":"Das UN (2013) Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 42:122\u2013134","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"10_CR77","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0924-977X(02)00130-X","volume":"13","author":"CC Chiu","year":"2003","unstructured":"Chiu CC, Huang SY, Su KP, Lu ML, Huang MC, Chen CC et al (2003) Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol 13(2):99\u2013103","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"10_CR78","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jpsychires.2012.11.004","volume":"47","author":"M Pomponi","year":"2013","unstructured":"Pomponi M, Janiri L, La Torre G, Di Stasio E, Di Nicola M, Mazza M et al (2013) Plasma levels of n-3 fatty acids in bipolar patients: deficit restricted to DHA. J Psychiatr Res 47(3):337\u2013342","journal-title":"J Psychiatr Res"},{"key":"10_CR79","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2017.12.025","volume":"233","author":"G Scola","year":"2018","unstructured":"Scola G, Versace A, Metherel AH, Monsalve-Castro LA, Phillips ML, Bazinet RP et al (2018) Alterations in peripheral fatty acid composition in bipolar and unipolar depression. J Affect Disord 233:86\u201391","journal-title":"J Affect Disord"},{"issue":"6","key":"10_CR80","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1176\/ajp.2006.163.6.1100","volume":"163","author":"ME Sublette","year":"2006","unstructured":"Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ (2006) Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 163(6):1100\u20131102","journal-title":"Am J Psychiatry"},{"key":"10_CR81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jad.2016.12.034","volume":"224","author":"V Ciappolino","year":"2017","unstructured":"Ciappolino V, Delvecchio G, Agostoni C, Mazzocchi A, Altamura AC, Brambilla P (2017) The role of n-3 polyunsaturated fatty acids (n-3PUFAs) in affective disorders. J Affect Disord 224:32\u201347","journal-title":"J Affect Disord"},{"issue":"6","key":"10_CR82","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1176\/appi.ajp.2016.15091228","volume":"173","author":"J Sarris","year":"2016","unstructured":"Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M et al (2016) Adjunctive nutraceuticals for depression: a systematic review and meta-analyses. Am J Psychiatry 173(6):575\u2013587","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10_CR83","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1192\/bjp.bp.110.084384","volume":"198","author":"MJ Owen","year":"2011","unstructured":"Owen MJ, O\u2019Donovan MC, Thapar A, Craddock N (2011) Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry 198(3):173\u2013175","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(01)00334-6","volume":"58","author":"MM Khan","year":"2002","unstructured":"Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP (2002) Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophr Res 58(1):1\u201310","journal-title":"Schizophr Res"},{"issue":"6","key":"10_CR85","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S0006-3223(00)00986-0","volume":"49","author":"J Assies","year":"2001","unstructured":"Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH (2001) Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 49(6):510\u2013522","journal-title":"Biol Psychiatry"},{"key":"10_CR86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.plefa.2016.03.010","volume":"108","author":"T Pawelczyk","year":"2016","unstructured":"Pawelczyk T, Trafalska E, Kotlicka-Antczak M, Pawelczyk A (2016) The association between polyunsaturated fatty acid consumption and the transition to psychosis in ultra-high risk individuals. Prostaglandins Leukot Essent Fatty Acids 108:30\u201337","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10_CR87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.prostaglandins.2017.08.010","volume":"133","author":"PB Shih","year":"2017","unstructured":"Shih PB, Morisseau C, Le T, Woodside B, German JB (2017) Personalized polyunsaturated fatty acids as a potential adjunctive treatment for anorexia nervosa. Prostaglandins Other Lipid Mediat 133:11\u201319","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10_CR88","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.plefa.2019.01.001","volume":"142","author":"K Satogami","year":"2019","unstructured":"Satogami K, Tseng PT, Su KP, Takahashi S, Ukai S, Li DJ et al (2019) Relationship between polyunsaturated fatty acid and eating disorders: systematic review and meta-analysis. Prostaglandins Leukot Essent Fatty Acids 142:11\u201319","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10_CR89","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000343970","volume":"28","author":"C Song","year":"2013","unstructured":"Song C (2013) Essential fatty acids as potential anti-inflammatory agents in the treatment of affective disorders. Mod Trends Pharmacopsychiatry 28:75\u201389","journal-title":"Mod Trends Pharmacopsychiatry"},{"key":"10_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnene.2013.00011","volume":"5","author":"JR Moffett","year":"2013","unstructured":"Moffett JR, Arun P, Ariyannur PS, Namboodiri AM (2013) N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation. Front Neuroenerg 5:11","journal-title":"Front Neuroenerg"},{"issue":"1","key":"10_CR91","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1811403","volume":"380","author":"JoAnn E. Manson","year":"2019","unstructured":"Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S et al (2019) Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Eng J Med 380(1):23\u201332","journal-title":"New England Journal of Medicine"},{"issue":"16","key":"10_CR92","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1804989","volume":"379","author":"L Bowman","year":"2018","unstructured":"Group ASC, Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G et al (2018) Effects of n-3 fatty acid supplements in diabetes mellitus. N Engl J Med 379(16):1540\u20131550","journal-title":"N Engl J Med"},{"issue":"19","key":"10_CR93","doi-asserted-by":"publisher","first-page":"8085","DOI":"10.1021\/ac901282n","volume":"81","author":"J Yang","year":"2009","unstructured":"Yang J, Schmelzer K, Georgi K, Hammock BD (2009) Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chem 81(19):8085\u20138093","journal-title":"Anal Chem"},{"issue":"4","key":"10_CR94","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.bbalip.2014.11.012","volume":"1851","author":"G Astarita","year":"2015","unstructured":"Astarita G, Kendall AC, Dennis EA, Nicolaou A (2015) Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids. Biochim Biophys Acta 1851(4):456\u2013468","journal-title":"Biochim Biophys Acta"},{"key":"10_CR95","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","volume":"9","author":"V Chiurchiu","year":"2018","unstructured":"Chiurchiu V, Leuti A, Maccarrone M (2018) Bioactive lipids and chronic inflammation: managing the fire within. Front Immunol 9:38","journal-title":"Front Immunol"},{"issue":"7454","key":"10_CR96","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12175","volume":"498","author":"T Lammermann","year":"2013","unstructured":"Lammermann T, Afonso PV, Angermann BR, Wang JM, Kastenmuller W, Parent CA et al (2013) Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498(7454):371\u2013375","journal-title":"Nature"},{"issue":"6","key":"10_CR97","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","volume":"50","author":"MW Buczynski","year":"2009","unstructured":"Buczynski MW, Dumlao DS, Dennis EA (2009) Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res 50(6):1015\u20131038","journal-title":"J Lipid Res"},{"issue":"1","key":"10_CR98","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/0973-1229.58822","volume":"8","author":"KS Latha","year":"2010","unstructured":"Latha KS (2010) The noncompliant patient in psychiatry: the case for and against covert\/surreptitious medication. Mens Sana Monogr 8(1):96\u2013121","journal-title":"Mens Sana Monogr"},{"key":"10_CR99","unstructured":"Shih PB, Yang J, Morisseau C, Calarge C (2017) American College of Neuropsychopharmacology annual meeting. Palm Springs, CA"},{"key":"10_CR100","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","volume":"53","author":"C Morisseau","year":"2013","unstructured":"Morisseau C, Hammock BD (2013) Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol 53:37\u201358","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"10_CR101","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/mp.2013.91","volume":"19","author":"AAS-V Zeeland","year":"2014","unstructured":"Zeeland AAS-V, Bloss CS, Tewhey R, Bansal V, Torkamani A, Libiger O et al (2014) Evidence for the role of EPHX2 gene variants in anorexia nervosa. Mol Psychiatry 19(6):724\u2013732","journal-title":"Mol Psychiatry"},{"issue":"13","key":"10_CR102","doi-asserted-by":"publisher","first-page":"E1944","DOI":"10.1073\/pnas.1601532113","volume":"113","author":"Q Ren","year":"2016","unstructured":"Ren Q, Ma M, Ishima T, Morisseau C, Yang J, Wagner KM et al (2016) Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress. Proc Natl Acad Sci U S A 113(13):E1944\u2013E1952","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR103","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pbb.2013.06.005","volume":"110","author":"M Ma","year":"2013","unstructured":"Ma M, Ren Q, Fujita Y, Ishima T, Zhang JC, Hashimoto K (2013) Effects of AS2586114, a soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine. Pharmacol Biochem Behav 110:98\u2013103","journal-title":"Pharmacol Biochem Behav"},{"issue":"8158","key":"10_CR104","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0140-6736(80)90553-X","volume":"1","author":"AA Mathe","year":"1980","unstructured":"Mathe AA, Sedvall G, Wiesel FA, Nyback H (1980) Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia. Lancet 1(8158):16\u201318","journal-title":"Lancet"},{"issue":"1","key":"10_CR105","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF01255817","volume":"77","author":"H Kaiya","year":"1989","unstructured":"Kaiya H, Uematsu M, Ofuji M, Nishida A, Takeuchi K, Nozaki M et al (1989) Elevated plasma prostaglandin E2 levels in schizophrenia. J Neural Transm 77(1):39\u201346","journal-title":"J Neural Transm"},{"issue":"3","key":"10_CR106","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1176\/ajp.146.3.365","volume":"146","author":"S Nishino","year":"1989","unstructured":"Nishino S, Ueno R, Ohishi K, Sakai T, Hayaishi O (1989) Salivary prostaglandin concentrations: possible state indicators for major depression. Am J Psychiatry 146(3):365\u2013368","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10_CR107","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0006-3223(88)90283-1","volume":"23","author":"K Ohishi","year":"1988","unstructured":"Ohishi K, Ueno R, Nishino S, Sakai T, Hayaishi O (1988) Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry 23(4):326\u2013334","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10_CR108","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0165-1781(86)90040-5","volume":"17","author":"JR Calabrese","year":"1986","unstructured":"Calabrese JR, Skwerer RG, Barna B, Gulledge AD, Valenzuela R, Butkus A et al (1986) Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res 17(1):41\u201347","journal-title":"Psychiatry Res"},{"issue":"4","key":"10_CR109","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0262-1746(83)90048-3","volume":"10","author":"J Lieb","year":"1983","unstructured":"Lieb J, Karmali R, Horrobin D (1983) Elevated levels of prostaglandin E2 and thromboxane B2 in depression. Prostaglandins Leukot Med 10(4):361\u2013367","journal-title":"Prostaglandins Leukot Med"},{"issue":"5567","key":"10_CR110","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1126\/science.1071702","volume":"296","author":"JR Vane","year":"2002","unstructured":"Vane JR (2002) Biomedicine. Back to an aspirin a day? Science 296(5567):474\u2013475","journal-title":"Science"},{"issue":"6 Pt 2","key":"10_CR111","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1164\/ajrccm.157.6.mar-2","volume":"157","author":"D Aharony","year":"1998","unstructured":"Aharony D (1998) Pharmacology of leukotriene receptor antagonists. Am J Respir Crit Care Med 157(6 Pt 2):S214\u2013S218. discussion S8\u20139, S47\u20138","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10_CR112","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00406-004-0478-1","volume":"254","author":"N Muller","year":"2004","unstructured":"Muller N, Ulmschneider M, Scheppach C, Schwarz MJ, Ackenheil M, Moller HJ et al (2004) COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. Eur Arch Psychiatry Clin Neurosci 254(1):14\u201322","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1\u20133","key":"10_CR113","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","volume":"121","author":"N Muller","year":"2010","unstructured":"Muller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M et al (2010) Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res 121(1\u20133):118\u2013124","journal-title":"Schizophr Res"},{"issue":"6","key":"10_CR114","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1055\/s-2004-832682","volume":"37","author":"N Muller","year":"2004","unstructured":"Muller N, Riedel M, Schwarz MJ (2004) Psychotropic effects of COX-2 inhibitors--a possible new approach for the treatment of psychiatric disorders. Pharmacopsychiatry 37(6):266\u2013269","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10_CR115","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hup.912","volume":"23","author":"FG Nery","year":"2008","unstructured":"Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN et al (2008) Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol 23(2):87\u201394","journal-title":"Hum Psychopharmacol"}],"container-title":["Advances in Experimental Medicine and Biology","The Role of Bioactive Lipids in Cancer, Inflammation and Related Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-21735-8_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T13:06:30Z","timestamp":1569589590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-21735-8_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030216368","9783030217358"],"references-count":115,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-21735-8_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"28 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}